About Alpelisib,Alpelisib
Class: | PI3K inhibitor
Use: | Alpelisib is indicated for the treatment of HR-positive, HER2-negative breast cancer in combination with endocrine therapy in postmenopausal women and men.
Adult dose: | The recommended dose is 300 mg taken orally once daily with food.
Pediatric dose: | Safety and efficacy in pediatric patients have not been established; not recommended for use in children.
Side effects: | Common side effects include hyperglycemia, diarrhea, nausea, rash, fatigue, and decre
Drug Class
PI3K inhibitor
Uses & Indications
Alpelisib is indicated for the treatment of HR-positive, HER2-negative breast cancer in combination with endocrine therapy in postmenopausal women and men.
Storage Requirements
Store at room temperature (20°C to 25°C or 68°F to 77°F) in a tightly closed container, protected from moisture.
Manufacturer & Packaging
Manufacturer: Novartis Pharmaceuticals Corporation, U.S.A
Package Size
56s
Price & Supplier
Price in UAE: AED 28240.50
Dosage Information
Adult Dose
The recommended dose is 300 mg taken orally once daily with food.
Pediatric Dose
Safety and efficacy in pediatric patients have not been established; not recommended for use in children.
Side Effects
Common side effects include hyperglycemia, diarrhea, nausea, rash, fatigue, and decreased appetite.
Contraindications & Precautions
Contraindicated in patients with a known hypersensitivity to alpelisib or any of its components.
Important Warnings
Monitor blood glucose levels regularly; may cause severe hyperglycemia. Risk of severe skin reactions and gastrointestinal toxicity. Use caution in patients with a history of diabetes or hyperglycemia.
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.